Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| L01CD02 | DOCETAXEL SPC | G | Docetaxel - 80mg/4ml | 80mg/4ml | Injectable concentrate for solution | 16906027.32 |
| L01CD02 | DOCETAXEL ACCORD | G | Docetaxel - 20mg/ml | 20mg/1ml | Injectable concentrate for solution | 4110814.2075 |
| L01CD02 | DOCETAXEL EBEWE | G | Docetaxel - 20mg/2ml | 20mg/2ml | Injectable solution | 5313553.245 |
| L01CD02 | DOCETAXEL GP PHARM | G | Docetaxel - 20mg/0.5ml | 20mg/0.5ml | Injectable concentrated solution+diluent | 4567720.6575 |
| L01CD02 | DOCETAXEL ACCORD | G | Docetaxel - 20mg/ml | 20mg/1ml | Injectable concentrate for solution | |
| L01CD02 | DOCETAXEL EBEWE | G | Docetaxel - 80mg/8ml | 80mg/8ml | Injectable solution | |
| L01BC08 | DACOGEN | B | Decitabine - 50mg | 50mg | Injectable lyophilised powder for solution | 90496389.096094 |
| L01BC08 | DACOGEN | B | Decitabine - 50mg | 50mg | Injectable lyophilised powder for solution | 90495926.139792 |
| L01BC06 | DIROGIT | G | Capecitabine - 500mg | 500mg | Tablet, film coated | 11330803.50675 |
| L01AX04 | DACARBAZINE MEDAC | G | Dacarbazine - 200mg | 200mg | Injectable powder for solution | 15866075.9124 |
| L01AX04 | DACARBAZINE MEDAC | G | Dacarbazine - 1,000mg | 1,000mg | Injectable powder for solution | 5411653.7475 |
| J07CA11 | DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE | B | Diphteria Toxoid1 - ≤25Lf (≥30IU)/0.5ml, Tetanus toxoid1 - ≥2.5Lf (≥40IU)/0.5ml, Bordetella pertussis (Whole cell) - ≤16OU (≥4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ≥10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ≤1.25mg , 2 conjugated to tetanos toxoid carrier protein - | Injectable suspension | 1515854.34 | |
| J05AR27 | DOLUTEGRAVIR/LAMIVUDINE/TENOFOVIR DISOPROXIL FUMARATE | G | Lamivudine - 300mg, Tenofovir disoproxil fumarate - 300mg, Dolutegravir - 50mg | Tablet | 54836160.435 | |
| J05AR24 | DELSTRIGO | B | Lamivudine - 300mg, Tenofovir disoproxil - 300mg, Doravirine - 100mg | Tablet, film coated | 48879792.534825 | |
| J04AB03 | DIARENTIS | B | Rifamycin sodium - 200mg | 200mg | Tablet, extended release | 1100671 |
| J02AC01 | DIFLUCAN | B | Fluconazole - 50mg | 50mg | Capsule | 622199.0775 |
Download the new version of the Ministry of Public Health application and discover new features providing reliable health information
and advanced digital services.
The new version allows you to scan medicine barcodes to verify whether the medication is officially registered with the Ministry of Public Health and distributed through approved official channels, contributing to enhanced patient safety and reducing counterfeit and illegal medicines. In addition to other healthcare services, including:
- Tracking medication records on MediTrack
- Locating the nearest healthcare facility
- Accessing information and statistics on nurseries
- Following the latest health news and updates
The Ministry encourages citizens to rely exclusively on the official application as a trusted source for accurate and reliable health information.
